Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy

Journal of ECT

Volumn 29, Issue 3, 2013, Pages 179-188

  Medda, Pierpaolo ^a   Mauri, Mauro ^a   Fratta, Sara ^a   Ciaponi, Benedetta ^a   Miniati, Mario ^a   Toni, Cristina ^a,b   Dell'Osso, Liliana ^a   Perugi, Giulio ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

Author keywords

Bipolar depression; Electroconvulsive therapy; Follow up; Mixed state; Relapse

Indexed keywords

MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; AGORAPHOBIA; ALCOHOL ABUSE; ANOREXIA; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BRIEF PSYCHIATRIC RATING SCALE; BULIMIA; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DEPRESSIVE PSYCHOSIS; DRUG TREATMENT FAILURE; DSM-IV; EATING DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW UP; HAMILTON SCALE; HOSPITALIZATION; HUMAN; HYPOMANIA; LONG TERM CARE; MAJOR DEPRESSION; MALE; MIXED MANIA AND DEPRESSION; NERVE STIMULATOR; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; OUTCOME ASSESSMENT; PANIC; RELAPSE; REMISSION; SOCIAL PHOBIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; SUICIDE ATTEMPT; SURVIVAL TIME; TREATMENT DURATION; YOUNG MANIA RATING SCALE;

ADULT; AGED; BIPOLAR DISORDER; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883561457     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3182887b7a     Document Type: Article

References (63)

1. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356:1711-1722
2. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: A controversy revisited. Am J Psychiatry. 1995;152:1130-1138
3. Ghaemi SN, Hsu DJ, Soldani F, et al. Antidepressants in bipolar disorder: The case for caution. Bipolar Disord. 2003;5:421-433
4. Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry. 2001;158:1265-1270
5. Post RM, Nolen WA, Kupka RW, et al. The Stanley Foundation Bipolar Network. I. Rationale and methods. Br J Psychiatry Suppl. 2001;41:s169Ys176
6. Perugi G, Akiskal HS, Micheli C, et al. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J Affect Disord. 2001;67:105-114
7. Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988;45:727-732
8. Calabrese JR, Fatemi SH, Kujawa M, et al. Predictors of response to mood stabilizers. J Clin Psychopharmacol. 1996;16(2 suppl 1): 24SY31S
9. Post RM. Non-lithium treatment for bipolar disorder. J Clin Psychiatry. 1990;51(suppl):9-16; discussion 17-19
10. Bailine S, Fink M, Knapp R, et al. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand. 2010;121:431-436
11. Sienaert P, Vansteelandt K, Demyttenaere K, et al. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: Differences in speed of response. Bipolar Disord. 2009;11:418-424
12. Medda P, Perugi G, Zanello S, et al. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. J ECT. 2010;26:82-6
13. Prudic J, Olfson M, Marcus SC, et al. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004;55:301-312
14. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10:96-104
15. Shapira B, Gorfine M, Lerer B. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convuls Ther. 1995;11:80-85
16. Seager CP, Bird RL. Imipramine with electrical treatment in depressionVa controlled trial. J Ment Sci. 1962;108:704-707
17. Kay DW, Fahy T, Garside RF. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry. 1970;117:667-671
18. Imlah NW, Ryan E, Harrington JA. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology. 1965;4:438-442
19. Huuhka M, Korpisammal L, Haataja R, et al. One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants. J ECT. 2004;20:179-185
20. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial. JAMA. 2001;285:1299-1307
21. Huuhka K, Viikki M, Tammentie T, et al. One-year follow-up after discontinuing maintenance electroconvulsive therapy. J ECT. 2012;28:225-228
22. Rasmussen KG, Mueller M, Rummans TA, et al. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). J Clin Psychiatry. 2009;70:232-237
23. Birkenhager TK, Renes JW, Pluijms EM. One-year follow-up after successful ECT: A naturalistic study in depressed inpatients. J Clin Psychiatry. 2004;65:87-91
24. Lauritzen L, Odgaard K, Clemmesen L, et al. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand. 1996;94:241-251
25. van Beusekom BS, van den Broek WW, Birkenhager TK. Long-term follow-up after successful electroconvulsive therapy for depression: A 4- to 8-year naturalistic follow-up study. J ECT. 2007;23:17-20
26. AmericanPsychiatricAssociation. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging. 2nd ed. Washington DC: American Psychiatric Association; 2001
27. Perugi G, Medda P, Zanello S, et al. Episode length and mixed features as predictors of ECT nonresponse in patients with medication-resistant major depression. Brain Stimul. 2012;5:18-24
28. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153:985-992
29. Aronson TA, Shukla S, Hoff A. Continuation therapy after ECT for delusional depression: A naturalistic study of prophylactic treatments and relapse. Convuls Ther. 1987;3:251-259
30. O'Leary DA, Lee AS. Seven year prognosis in depression. Mortality and readmission risk in the Nottingham ECT cohort. Br J Psychiatry. 1996;169:423-429
31. Nordenskjold A, von Knorring L, Engstrom I. Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: A population-based cohort study. Depress Res Treat. 2011;2011:470985
32. van den Broek WW, Birkenhager TK, Mulder PG, et al. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: A randomized, placebo-controlled trial. J Clin Psychiatry. 2006;67:263-268
33. Birkenhager TK, van den Broek WW, Mulder PG, et al. One-year outcome of psychotic depression after successful electroconvulsive therapy. J ECT. 2005;21:221-226
34. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IVand ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33;quiz 34-57
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62
36. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435
37. Overall JE, Gorham D. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812
38. Guy W. ECDEU Assessment Manual for Psychopharmacology. Revised, 1976. DHEW Publication No. (ADM) ed. 1976. 76-338
39. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44:540-548
40. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;7:3-5
41. Petrides G, Fink M. The ''half-age''stimulation strategy for ECT dosing. Convuls Ther. 1996;12:138-146
42. Bourgon LN, Kellner CH. Relapse of depression after ECT: A review. J ECT. 2000;16:19-31
43. Serby M. Manic reactions to ECT. Am J Geriatr Psychiatry. 2001;9:180
44. Kukopulos A, Reginaldi D, Laddomada PA, et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol. 1980;13:156-167
45. Angst J, Angst K, Baruffol I, et al. ECT-induced and drug-induced hypomania. Convuls Ther. 1992;8:179-185
46. Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: New directions for research. J Clin Psychopharmacol. 1993;13:397-408
47. Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10:85-116
48. Versiani M, Cheniaux E, Landeira-Fernandez J. Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder: A systematic review. J ECT. 2011;27:153-164
49. Strakowski SM, Williams JR, Fleck DE, et al. Eight-month functional outcome from mania following a first psychiatric hospitalization. J Psychiatr Res. 2000;34:193-200
50. Tohen M, Hennen J, Zarate CM JR, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157:220-228
51. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63:1337-1344
52. Sackeim HA, Portnoy S, Neeley P, et al. Cognitive consequences of low-dosage electroconvulsive therapy. Ann N Y Acad Sci. 1986;462:326-340
53. Squire LR. Memory functions as affected by electroconvulsive therapy. Ann N Y Acad Sci. 1986;462:307-314
54. Silfverskiold P, Gustafson L, Risberg J, et al. Acute and late effects of electroconvulsive therapy. Clinical outcome, regional cerebral blood flow, and electroencephalogram. Ann N Y Acad Sci. 1986;462:236-248
55. Brodaty H, Hickie I,Mason c, et al. A prospective follow-up study of ECT outcome in older depressed patients. J Affect Disord. 2000;60:101-111
56. Gagné GG Jr, Furman MJ, Carpenter LL, et al. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry. 2000;157:1960-1965
57. Magni GG, Fisman M, Helmes E. Clinical correlates of ECT-resistant depression in the elderly. J Clin Psychiatry. 1988;49:405-407
58. Black DW, Winokur G, Nasrallah A. A multivariate analysis of the experience of 423 depressed inpatients treated with electroconvulsive therapy. Convuls Ther. 1993;9:112-120
59. Kho KH, Zwinderman AH, Blansjaar BA. Predictors for the efficacy of electroconvulsive therapy: Chart review of a naturalistic study. J Clin Psychiatry. 2005;66:894-899
60. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):10-17
61. Dombrovski AY, Mulsant BH, Haskett RF, et al. Predictors of remission after electroconvulsive therapy in unipolar major depression. J Clin Psychiatry. 2005;66:1043-1049
62. Sheline YI, Mittler BL, Mintun MA. The hippocampus and depression. Eur Psychiatry. 2002;17(suppl 3):300-305
63. Piccinni A, Del Debbio A, Medda P, et al. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur Neuropsychopharmacol. 2009;19:349-355